|
Related Companies
|
[]
|
||||||||
|
Related Funds
|
[]
|
||||||||
|
|
|||||||||
|
English
|
|||||||||
|
oda_MaterialEventDisclosureGeneralAbstract|
|
|
||||||||
|
oda_UpdateAnnouncementFlag|
|
|
Hayır (No)
|
|||||||
|
oda_CorrectionAnnouncementFlag|
|
|
Hayır (No)
|
|||||||
|
oda_DateOfThePreviousNotificationAboutTheSameSubject|
|
|
-
|
|||||||
|
oda_DelayedAnnouncementFlag|
|
|
Hayır (No)
|
|||||||
|
oda_AnnouncementContentSection|
|
|
||||||||
|
oda_ExplanationSection|
|
|
||||||||
|
oda_ExplanationTextBlock|
|
At the meeting of our Board of Directors held on 25.11.2025, it was resolved that, effective as of 01.01.2026;
- Mr. Ali Tuna Gürgen be appointed as Deputy General Manager,
- Mr. Mahir Balıkçı be appointed as Director of Audit and Efficiency Analyses,
- Mr. Şanver Baytekin be appointed as Director of Sales and Supplier Relations,
- Mr. Fikret Yıldırım be appointed as Director of Non-Pharmaceutical Products Procurement, Sales and Payments, and
- Mr. Ferhat İpşir be appointed as Director of Pharmaceutical Procurement, Operations and Payments.
In case of any discrepancy between the Turkish and English versions of this public disclosure, the Turkish version shall prevail.
|
||||||||